ArticlePhysical and engineering sciences in medicine2025
Advantages of carbon fibre-reinforced polyetheretherketone over titanium implants in spine SBRT: a phantom evaluation.
Article in Physical and engineering sciences in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluates the clinical feasibility of spine stereotactic body radiotherapy (SBRT) in the presence of titanium and carbon fibre-reinforced polyetheretherketone (CFR-PEEK) spinal implants using custom 3D-printed phantoms. The investigation focuses on the dosimetric accuracy, imaging challenges, and achievable localisation precision. Customised 3D-printed phantoms incorporating titanium and CFR-PEEK implants were computed tomography (CT) scanned, with and without metal artefact reduction (MAR) algorithms. Localisation accuracy was tested using Elekta XVI CBCT and Brainlab ExacTrac Dynamic. The dosimetric accuracy of the Monaco treatment planning system (TPS) was assessed under simple geometric conditions and for clinically realistic VMAT plans. Patient-specific quality assurance and phantom-based measurements using ionization chambers and radiochromic film were performed to evaluate delivered dose accuracy. Both Image Guided Radiotherapy (IGRT) systems achieved sub-millimetre localisation accuracy, with maximum deviations of 0.3 mm observed for titanium implants. The Monaco treatment planning system (TPS) demonstrated accurate dose modelling, with deviations < 1% for CFR-PEEK and < 2% for titanium implants in simple homogeneous arrangements. In complex VMAT plan deliveries, dosimetric measurements showed stronger agreement with TPS predictions for CFR-PEEK implants, with deviations < 3%. Titanium-based plans exhibited greater deviations, with localised dose discrepancies exceeding clinical tolerances of 5%. The application of MAR algorithms reduced these discrepancies to < 5%, ensuring clinically acceptable dosimetric accuracy. CFR-PEEK implants enhance clinical workflows due to reduced imaging artefacts and smoother dose distributions, making MAR corrections unnecessary. For titanium implants, MAR is essential to achieve clinically acceptable dosimetric accuracy, highlighting the robustness of CFR-PEEK for spine SBRT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.